series-a
Stage
1
Investors
About
Ixgene develops precision oncology therapeutics that selectively target tumors while sparing healthy tissue, leveraging proprietary target selection pipelines and scientific methodologies focused on molecular differences in cancer.
Explore 株式会社iXgene's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.